INIBIDORES DAS TIROSINACINASES NA TERAPÊUTICA FARMACOLÓGICA

The discovery of mutations in tyrosine kinases (TKs) involved in the pathogenesis of many diseases, particularly oncological, encouraged the investigation of inhibitors of tyrosine kinases (ITKs) as therapeutic strategies. The aim of this study was to perform a review of the different ITKs availabl...

Full description

Bibliographic Details
Main Authors: Sara Saraiva, Sandra Morgado, Manuel Morgado
Format: Article
Language:English
Published: Formifarma, LDA. 2013-09-01
Series:Revista Portuguesa de Farmacoterapia
Subjects:
Online Access:http://farmacoterapia.pt/index.php/rpf/article/view/44